SynCore Bio Enrolled First Patient In Phase III Trial for SB05 Pancreatic Cancer in Hungary
Taipei, Taiwan, 14 January 2019. SynCore Biotechnology Co. (4192:TT) announces [...]
Taipei, Taiwan, 14 January 2019. SynCore Biotechnology Co. (4192:TT) announces [...]